Covaxin may get WHO approval in October, waiting for Bharat Biotech to end

0
13

Final approval for Covaxin is expected to be completed by October. A meeting of the Strategic Advisory Group of Experts is to be held in October in connection with WHO’s approval for emergency use.

Geneva: Awaiting the approval of the World Health Organization (WHO) regarding covaxincovid-19 vaccine Bharat Biotech is about to end.

ICYMI: India pulls up Pakistan at UNHRC, demands credible action against terrorism

final approval for covaxin Expected to be completed by October. A meeting of the Strategic Advisory Group of Experts is to be held in October in connection with WHO’s approval for emergency use.

Regarding this meeting to be held on October 5, it is expected that Bharat Biotech’s Biochem Vaccine can get green signal from WHO in this.

Bharat Biotech had submitted the EoI (Expression of Interest) on April 19 for its coronavirus vaccine. Decision on Bharat Biotech says information on status of evaluation of COVID-19 vaccines on WHO website covaxin Coming on 21st October.

Read also: China facing economic crisis as power crisis paralyzes sugar industry

According to WHO, submissions made by WHO for prequalification or listing under the emergency use procedure are confidential. If a product submitted for evaluation is found to meet the listing criteria, WHO will publish the results widely. The WHO said the organization is reviewing the data provided by Bharat Biotech on 6 July.

According to the agency, the duration of the emergency use list process depends on the quality of the data submitted by the coronavirus vaccine manufacturer and whether the data meets WHO criteria. Bharat Biotech’s Covaxin and AstraZeneca and Oxford University’s Covishield are the two widely used COVID-19 vaccines in India.

Read more: American journalist angry at Joe Biden praising Indian media

Bharat Biotech recently said that the company has handed over all the data related to covaxin Awaiting a decision on this from the EUL to the WHO and from the global health watchdog. The company said that all data for emergency use covaxin was made available to WHO in July.

First published:September 30, 2021, 3:09 pm

Leave a Reply